Lexicon Pharmaceuticals | LXRX - Ebit





Ebit Alterar Data
Abbott USD 2.13B 281M 2026-06
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Illumina USD 260M 21M 2026-06
Insmed USD -200.28M 49.43M 2026-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 7.48B 860M 2026-06
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -31.88M 19.79M 2026-03
MannKind USD -76.99M 7.75M 2026-03
Merck USD -1.88B 8.12B 2026-03
Moderna USD -815M 573M 2026-06
Novartis USD 4.73B 549M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vanda Pharmaceuticals USD -10.28M 721K 2024-12